Skip to Main Content
  • Linde Worldwide
  • The Linde Group
  • About Linde
  • Careers
  • Glossary
  • Healthcare
    Sri Lanka

  • Home
  • About COL Healthcare
      • Mission
      • Healthcare professionals
      • Patient-focused care
      • Innovation
        • Innovation in healthcare
        • Your partner
        • REALfund
      • Key figures
      • Locations
  • Products and Services
      • Products and Services by category
        • Hospital equipment
          • Homecare devices, e.g., concentrators, masks
        • Medical gases
          • Calibration gases
          • Medical carbon dioxide
          • Medical cardiopulmonary testing gases
          • Medical helium/oxygen mixtures
          • Medical nitrogen
          • Medical air
          • Medical nitrous oxide
          • Medical nitrous oxide/oxygen mixtures
          • Medical oxygen
        • QI Medical Gas Services
          • The Service Centric Programme
      • Products and Services by disease area
        • Anaesthesia
          • Medical air
          • Medical oxygen
          • Medical nitrous oxide
          • Medical nitrous oxide/oxygen mixtures
        • Intensive care
          • Medical helium/oxygen mixtures
          • Medical oxygen
        • Obstetrics
          • Medical nitrous oxide/oxygen mixtures
        • Pain
          • Medical nitrous oxide/oxygen mixtures
        • Pulmonology
          • Medical cardiopulmonary testing gases
          • Medical oxygen
      • Products and Services by care area
        • Emergency care
          • Medical nitrous oxide/oxygen mixtures
          • Medical oxygen
          • Supplies and accessories
        • Hospital and clinical care
          • Medical air
          • Medical nitrous oxide
          • Medical nitrous oxide/oxygen mixtures
          • Medical oxygen
  • News & Media
      • Sri Lanka News
      • Global news
      • Events
        • Events Archive
      • Publications
      • Image Library
      • BroadcastRoom
      • Media Contacts
  •  
  • Linde Worldwide
  • The Linde Group
  • About Linde
  • Careers
  • Glossary
  • News & Media
  • Sri Lanka News
  • Global news
  • Events
  • Publications
  • Image Library
  • BroadcastRoom
  • Media Contacts
  • News & Media
  • Global news
  • 2012-07-03 Linde signs contract for second linear alpha olefin plant with Alpha-SABLIN® process

Linde signs contract for second linear alpha olefin plant with Alpha-SABLIN® process

Trade News

Munich, 3 July 2012 - Linde Engineering, a division of The Linde Group, is set to build a new Alpha-SABLIN® plant for the production of linear alpha olefins (LAO) in Nizhnekamsk, Russian Federation, which upon completion will be operated by Nizhnekamskneftekhim (NKNH), a leading Russian petrochemical producer.

NKNH awarded Linde Engineering contracts for license, basic/detail engineering and supply of equipment and materials for revamping of NKNH's existing LAO plant.

The plant is expected to come on-stream by mid of 2014, supplying NKNH with 37.5 kta linear alpha olefins with maximized production of C4 and C6 fractions. The revamp project will partially make use of the existing equipment of NKNH’s former LAO plant with implementation of Alpha-SABLIN® technology.

Alpha-SABLIN® is a superior and flexible full range process for the production of linear alpha olefins by selective catalytic oligomerization of polymer grade ethylene, jointly developed and owned by Linde Engineering and Saudi Basic Industries Corporation (SABIC).

"The project is a major breakthrough for Alpha-SABLIN® and will strengthen our growing position in the market segment for linear alpha olefins," says Florian Penner, Product Manager LAO at Linde Engineering Division. "It proves the excellent reputation of this new technology derived in a relatively short period after full commercialization in 2009."

Since 2009 the first full scale Alpha-SABLIN® plant with a capacity of 150 kta linear alpha olefins built for Jubail United Petrochemical Company (UNITED) in Al Jubail, Kingdom of Saudi Arabia, has successfully demonstrated the outstanding performance and profitability of the Alpha-SABLIN® process.

 

About The Linde Group

The Linde Group is a world-leading gases and engineering company with around 50,500 employees in more than 100 countries worldwide. In the 2011 financial year, it generated revenue of EUR 13.787 bn. The strategy of The Linde Group is geared towards long-term profitable growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment – in every one of its business areas, regions and locations across the globe. The Group is committed to technologies and products that unite the goals of customer value and sustainable development.

For more information, see The Linde Group online at http://www.linde.com.

 

Contact

Florian Penner
Product Manager LAO
Phone: +49.89.7445-2213
E-Mail: florian.penner@  

Doreen Schüßler
Manager Press and Media 
Phone: +44.89.7445-3495
E-Mail: doreen.schuessler@

    •  
    • Sitemap
    • Terms of Use
    • Legal Notice
    • Data Protection
  • © Ceylon Oxygen Limited 2015

The Linde Group would like to use cookies to store information on your computer, to improve our websites.
The Linde Group would like to use cookies to store information on your computer, to improve our websites. Some cookies are essential for our sites to operate and have already been set. You may delete and block all cookies from this site, but parts of the site may not work. To find out more about the cookies we use and how to delete them, see our information on data protection.
You must check the "I accept cookies from Linde Sites" box to accept.
More